New York Attorney General Letitia James, Georgia Attorney General Christopher Carr, and New Jersey Attorney General Matthew Platkin filed a complaint against Fresenius Vascular Care, one of its New York-based executives, Gregg Miller, and several of their affiliates “for subjecting Medicaid recipients with end-stage renal disease to unnecessary surgeries and defrauding the New York state Medicaid program.” The defendants allegedly scheduled ESRD patients for appointments every three to four months purportedly to preserve their dialysis access sites. “At these appointments, the defendants sedated the patients and performed invasive procedures on their veins and arteries, putting already vulnerable patients at a heightened risk of grave complications,” the attorneys general said in a statement. This lawsuit seeks damages and penalties under the New York False Claims Act and other state laws.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FMS:
- Fresenius Medical upgraded to Neutral from Sell at UBS
- BJ’s Wholesale names Anjana Harve as chief information officer
- Fresenius Medical price target raised to EUR 40.50 at Morgan Stanley
- Fresenius Medical downgraded to Neutral from Buy at UBS
- Fresenius Medical price target raised to EUR 46 from EUR 38 at Deutsche Bank